Overview

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if glucose peaks higher and earlier after a meal when a patient is given intranasal insulin instead of conventional insulin treatment.
Phase:
Phase 2
Details
Lead Sponsor:
CPEX Pharmaceuticals Inc.
Treatments:
Insulin
Insulin Aspart
Insulin, Globin Zinc